JFA
IMMU

JNBA Financial Advisors’s Immunomedics Inc IMMU Stock Holding History

JNBA Financial Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,300
Closed -$5K – 554
2015
Q1 		$5K Hold
1,300
– – ﹤0.01% 430
2014
Q4 		$6K Hold
1,300
– – ﹤0.01% 409
2014
Q3 		$5K Hold
1,300
– – ﹤0.01% 447
2014
Q2 		$5K Hold
1,300
– – ﹤0.01% 410
2014
Q1 		$5K Buy
+1,300
New +$6.45K ﹤0.01% 386

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JNBA Financial Advisors's IMMU Position: Q2 2015 in Review

JNBA Financial Advisors sold out of Immunomedics Inc (IMMU) in Q2 2015, closing a stake of 1,300 shares — an estimated $5K sold.

JNBA Financial Advisors first reported a position in IMMU in Q1 2014 and held it in 5 quarters. The position peaked at $6K in Q4 2014. 85 funds tracked by Wall St. Rank hold IMMU as of Q2 2015.

  • JNBA Financial Advisors reported no remaining Immunomedics Inc position as of Q2 2015 after selling out during the quarter.
  • JNBA Financial Advisors sold 1,300 Immunomedics Inc shares in Q2 2015, an estimated $5K.
  • JNBA Financial Advisors first reported a position in Immunomedics Inc in Q1 2014 and held it in 5 quarters.
  • JNBA Financial Advisors's Immunomedics Inc position peaked at $6K in Q4 2014.
  • 85 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2015.

Based on JNBA Financial Advisors's 13F filing for Q2 2015, filed 29 Jul 2015.